These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 418941)

  • 21. Proceedings: On the role of diuretic-and spironolactone-induced hyperaldosteronism on electrolyte excretion in man.
    Erbler H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R19. PubMed ID: 4276539
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of spironolactone for the diagnosis of primary aldosteronism.
    Himathongkam T; Kaojarern S; Shaipanich T; Israngkul W
    J Med Assoc Thai; 1979 Mar; 62(3):129-41. PubMed ID: 429942
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary aldosteronism: observations on water and electrolyte changes during partial immersion.
    Crane MG; Harris JJ
    J Clin Endocrinol Metab; 1973 Nov; 37(5):790-6. PubMed ID: 4749453
    [No Abstract]   [Full Text] [Related]  

  • 24. [Primary hyperaldosteronism: differentiation between adenoma and primary hyperplasia of the adrenal glands and operative indications].
    Fournier A
    Presse Med (1893); 1971 Dec; 79(54):2492-3. PubMed ID: 5157901
    [No Abstract]   [Full Text] [Related]  

  • 25. Estimation of plasma potassium, renin and aldosterone in the diagnosis of primary hyperaldosteronism; the role of spironolactone in the treatment of this syndrome.
    Brown JJ; Chinn RH; Dusterdieck G; Fraser R; Lever AF; Robertson JI; Tree M
    J Endocrinol; 1969 Jan; 43(1):iv-v. PubMed ID: 5773780
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary hyperaldosteronism--diagnostic approach and management.
    Seshadri MS; Kanagasabapathy AS; Cherian AM; Nair A; Jesudason SR
    J Assoc Physicians India; 1993 May; 41(5):266-8. PubMed ID: 8300455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conns' syndrome - atypical presentations.
    Hari Kumar K; Jha S; Jha R; Modi KD
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):278-81. PubMed ID: 19237819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diagnosis and therapy of primary hyperaldosteronism].
    Hodler J
    Schweiz Med Wochenschr; 1972 Jul; 102(30):1039-44. PubMed ID: 4572955
    [No Abstract]   [Full Text] [Related]  

  • 29. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?
    Juutilainen AM; Voutilainen ET; Mykkänen L; Niskanen L
    Blood Press; 2005; 14(4):245-50. PubMed ID: 16126559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnosis and treatment of primary aldosteronism].
    Wang GY
    Zhonghua Wai Ke Za Zhi; 1992 Nov; 30(11):677-9, 700. PubMed ID: 1307299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary hyperaldosteronism.
    Nadar S; Lip GY; Beevers DG
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):439-52. PubMed ID: 14503982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Periodic paralysis associated with hyperthyroidism. Study of the precipitating factors.
    Pereira VG; Wajchenberg BL; Quintão ER
    Arq Bras Endocrinol Metabol; 1968 Jan; 17(1):55-67. PubMed ID: 5739587
    [No Abstract]   [Full Text] [Related]  

  • 35. Saline suppression of plasma aldosterone in hypertension.
    Kem DC; Weinberger MH; Mayes DM; Nugent CA
    Arch Intern Med; 1971 Sep; 128(3):380-6. PubMed ID: 5093210
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary aldosteronism -- screening, diagnosis and therapy.
    Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E
    Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of arterial hypertensive disease with diuretics. V. Spironolactone, an aldosterone antagonist.
    Johnston LC; Grieble HG
    Arch Intern Med; 1967 Mar; 119(3):225-31. PubMed ID: 6020067
    [No Abstract]   [Full Text] [Related]  

  • 38. Re-evaluation of the fludrocortisone test: duration, NaCl supplementation and cut-off limits for aldosterone.
    Westerdahl C; Bergenfelz A; Larsson J; Nerbrand C; Valdemarsson S; Wihl A; Isaksson A
    Scand J Clin Lab Invest; 2009; 69(2):234-41. PubMed ID: 18951242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advantage of a high-sodium diet in the diagnosis of hyperaldosteronism.
    Demanet JC; Vryens R
    Horm Metab Res; 1971 Nov; 3(6):442-5. PubMed ID: 5131529
    [No Abstract]   [Full Text] [Related]  

  • 40. A simple method for definition of incomplete suppression of aldosterone and its association with hypertension and hypokalaemia in man.
    Adam WR
    Clin Sci (Lond); 1986 Oct; 71(4):375-83. PubMed ID: 3757436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.